Finance

Lists
NATCOPHARM:NSE
Natco Pharma Ltd
₹794,80
-1,89%
(-15,30) 1D
8 ຕ.ລ., 15 ໂມງ 30 ນາທີ 00 ວິນາທີ GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
₹812,95
High
₹819,00
Low
₹792,10
Mkt. cap
142,63 ຕື້
Avg. vol.
445,26 ພັນ
Volume
312,12 ພັນ
Dividend
0,56%
Quarterly dividend
₹1,12
Ex-dividend date
20 ສ.ຫ. 2026
P/E ratio
12,54
52-wk high
₹1.216,89
52-wk low
₹785,65
EPS
₹63,37
Shares outstanding
182,26 ລ້ານ
No. of employees
4 ພັນ
Open
₹812,95
High
₹819,00
Low
₹792,10
Mkt. cap
142,63 ຕື້
Avg. vol.
445,26 ພັນ
Volume
312,12 ພັນ
Dividend
0,56%
Quarterly dividend
₹1,12
Ex-dividend date
20 ສ.ຫ. 2026
P/E ratio
12,54
52-wk high
₹1.216,89
52-wk low
₹785,65
EPS
₹63,37
Shares outstanding
182,26 ລ້ານ
No. of employees
4 ພັນ
News stories
From web sources and news partners
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4,43 ພັນ
Founded1981
HeadquartersBanjara Hills, ເຕລັງຄານາ, ອິນເດຍ
SectorPharmaceutical industry
Last report
14 ສ.ຫ. 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹11,53 / ₹8,86
+30,06%beat
Revenue / Est. (INR)
7,35 ຕື້ / 7,96 ຕື້
-7,66%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
13,63 ຕື້
6,47 ຕື້
7,43 ຕື້
7,35 ຕື້
Cost of goods sold
1,70 ຕື້
1,33 ຕື້
1,99 ຕື້
1,48 ຕື້
Cost of revenue
1,70 ຕື້
1,33 ຕື້
1,99 ຕື້
1,48 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,00 ຕື້
1,59 ຕື້
1,63 ຕື້
1,79 ຕື້
Operating expense
6,66 ຕື້
4,02 ຕື້
4,38 ຕື້
4,48 ຕື້
Total operating expenses
8,36 ຕື້
5,35 ຕື້
6,37 ຕື້
5,96 ຕື້
Operating income
5,27 ຕື້
1,12 ຕື້
1,06 ຕື້
1,39 ຕື້
Other non operating income
1,00 ຕື້
581,00 ລ້ານ
-2,11 ຕື້
592,00 ລ້ານ
EBT including unusual items
6,14 ຕື້
1,72 ຕື້
1,80 ຕື້
2,70 ຕື້
EBT excluding unusual items
6,14 ຕື້
1,72 ຕື້
2,02 ຕື້
2,70 ຕື້
Income tax expense
958,00 ລ້ານ
207,00 ລ້ານ
-892,00 ລ້ານ
634,00 ລ້ານ
Effective tax rate
15,61%
12,03%
-49,61%
23,49%
Other operating expenses
4,14 ຕື້
1,96 ຕື້
2,23 ຕື້
2,22 ຕື້
Net income
5,18 ຕື້
1,52 ຕື້
2,68 ຕື້
2,06 ຕື້
Net profit margin
38,03%
23,40%
36,08%
28,09%
Earnings per share
28,94
8,46
14,96
11,53
Interest and investment income
-
-
2,33 ຕື້
-
Interest expense
-131,00 ລ້ານ
-95,00 ລ້ານ
-
-130,00 ລ້ານ
Net interest expenses
-131,00 ລ້ານ
-95,00 ລ້ານ
2,33 ຕື້
-130,00 ລ້ານ
Depreciation and amortization charges
524,00 ລ້ານ
462,00 ລ້ານ
504,00 ລ້ານ
471,00 ລ້ານ
EBITDA
5,82 ຕື້
1,57 ຕື້
1,55 ຕື້
1,91 ຕື້
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
ແອັບຂອງ Google